guest ::
| Home > Publications database > Chronic Active Epstein-Barr Virus Infection controlled by allogeneic stem cell transplantation and EBV-specific T-cells. > print |
| Home > Publications database > Chronic Active Epstein-Barr Virus Infection controlled by allogeneic stem cell transplantation and EBV-specific T-cells. > print |
| 001 | 274183 | ||
| 005 | 20240229154927.0 | ||
| 024 | 7 | _ | |a 10.1093/cid/ciad131 |2 doi |
| 024 | 7 | _ | |a pmid:36883586 |2 pmid |
| 024 | 7 | _ | |a 1058-4838 |2 ISSN |
| 024 | 7 | _ | |a 0162-0886 |2 ISSN |
| 024 | 7 | _ | |a 1537-6591 |2 ISSN |
| 024 | 7 | _ | |a altmetric:143418420 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2023-00478 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Meedt, Elisabeth |b 0 |
| 245 | _ | _ | |a Chronic Active Epstein-Barr Virus Infection controlled by allogeneic stem cell transplantation and EBV-specific T-cells. |
| 260 | _ | _ | |a Oxford |c 2023 |b Oxford Journals |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1687350338_6280 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2023 Jun 16;76(12):2200-2202 |
| 520 | _ | _ | |a We report sustained remission of chronic active EBV infection in a 27-year-old female patient treated with third-party EBV-specific T-cells followed by allogeneic HSCT. The viremia cleared after administration of anti-T-lymphocyte globulin for GvHD prophylaxis. Subsequent expansion of EBV-infected host T-cells was controlled by transfusion of donor-derived EBV-specific T-cells. |
| 536 | _ | _ | |a 316 - Infektionen, Entzündung und Krebs (POF4-316) |0 G:(DE-HGF)POF4-316 |c POF4-316 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a CAEBV |2 Other |
| 650 | _ | 7 | |a EBV-specific T-cells |2 Other |
| 650 | _ | 7 | |a allogeneic stem cell transplantation |2 Other |
| 650 | _ | 7 | |a anti-T-lymphocyte globulin |2 Other |
| 700 | 1 | _ | |a Weber, Daniela |b 1 |
| 700 | 1 | _ | |a Bonifacius, Agnes |b 2 |
| 700 | 1 | _ | |a Eiz-Vesper, Britta |b 3 |
| 700 | 1 | _ | |a Maecker-Kolhoff, Britta |b 4 |
| 700 | 1 | _ | |a Delecluse, Susanne |0 P:(DE-He78)3877ae274d0271d6bf311bb46539f013 |b 5 |u dkfz |
| 700 | 1 | _ | |a Delecluse, Henri-Jacques |0 P:(DE-He78)25d3c74b949988c637571e696fc04b25 |b 6 |u dkfz |
| 700 | 1 | _ | |a Lorenz, Myriam |b 7 |
| 700 | 1 | _ | |a Schwarz, Klaus |b 8 |
| 700 | 1 | _ | |a Meedt, Stefan T |b 9 |
| 700 | 1 | _ | |a Braess, Jan |b 10 |
| 700 | 1 | _ | |a Herr, Wolfgang |b 11 |
| 700 | 1 | _ | |a Holler, Ernst |b 12 |
| 700 | 1 | _ | |a Edinger, Matthias |b 13 |
| 700 | 1 | _ | |a Wolff, Daniel |b 14 |
| 773 | _ | _ | |a 10.1093/cid/ciad131 |g p. ciad131 |0 PERI:(DE-600)2002229-3 |n 12 |p 2200-2202 |t Clinical infectious diseases |v 76 |y 2023 |x 1058-4838 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:274183 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)3877ae274d0271d6bf311bb46539f013 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)25d3c74b949988c637571e696fc04b25 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-316 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Infektionen, Entzündung und Krebs |x 0 |
| 914 | 1 | _ | |y 2023 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2022-11-08 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-08 |
| 915 | _ | _ | |a National-Konsortium |0 StatID:(DE-HGF)0430 |2 StatID |d 2023-08-24 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CLIN INFECT DIS : 2022 |d 2023-08-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-08-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-08-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-08-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-08-24 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-08-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-08-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-08-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-08-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-08-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-08-24 |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b CLIN INFECT DIS : 2022 |d 2023-08-24 |
| 920 | 1 | _ | |0 I:(DE-He78)F100-20160331 |k F100 |l F100 Pathologie infektionsbedingter Tumoren |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)F100-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|